Type 2 Diabetes Increases the Risk of Serious and Life-Threatening Conditions Among Adults with Traumatic Spinal Cord Injury

About 38 million adults in the United States have type 2 diabetes (T2D), a complex metabolic disease that impairs the body’s ability to produce or respond to the insulin hormone. For adults with a traumatic spinal cord injury (TSCI), T2D has been linked to a delayed healing of pressure sores, higher incidence of microvascular and macrovascular conditions, and higher health care costs. Adults living with TSCI have a 66% higher risk of developing T2D than the general population, and like the general population, having this disease carries an increased risk of developing serious and life-threatening conditions.

A study led by Michelle Meade, PhD, Director of the University of Michigan Center for Disability Health and Wellness and Principal Investigator of the Investigating Disability factors and promoting Environmental Access for healthy Living Rehabilitation Research and Training Center (IDEAL RRTC) and Michigan Spinal Cord Injury Model System (MI-SCIMS) research projects, found that adults with TSCI and T2D had a greater chance of developing a range of dangerous conditions. The research found significant higher rates of sepsis, heart attack, bone infection, and stroke. Black or Hispanic individuals were significantly more likely to have been diagnosed with T2D compared to adults who identified as White or Asian and were, therefore, more likely to develop any of the conditions associated with TSCI and T2D.

Visual infographic representing Type 2 Diabetes Increases the risk of serious and life-threatening conditions among adults with traumatic spinal cord injury

Implications

For adults living with SCI, this study highlights the importance of regular screening for T2D and attention to T2D management. Moreover, people with SCI need to be aware of their unique symptoms and concerns when identifying and managing the condition.

For health care providers, this study emphasizes the importance of identifying and partnering with patients with SCI to prevent and manage chronic health conditions for which they are at higher risk. Type 2 diabetes is a serious condition but one that can be prevented and managed. Doing so requires regular screening and tailoring clinical standards to this patient population. The authors cited two potential examples:

  • A T2D diagnosis may be missed due to masked symptoms, such as excessive urination accounted for by catheter use.
  • In terms of managing the condition, glucose monitoring tools built for individuals with reduced fine motor movements should be made available.

Physicians are invited to review the American Diabetes Association’s 2023 Standards of Care in Diabetes, which includes all of the ADA's current clinical practice recommendations for effective T2D care and management.

A patient-friendly version is available here.

For more information:

Meade, M. A., Yin, Z., Lin, P., Kamdar, N., Rodriguez, G., McKee, M., & Peterson, M. D. (2023). Type 2 diabetes increases the risk of serious and life-threatening conditions among adults with traumatic spinal cord injury. Mayo Clinic Proceedings. Innovations, Quality & Outcomes, 7(5), 452–461. https://doi.org/10.1016/j.mayocpiqo.2023.08.002

This research was developed in part under two grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (IDEAL RRTC, NIDILRR #90RTHF0001, and MI SCIMS, NIDILRR #90SIMS0018) and the Craig H. Neilsen Foundation (PSR2-17-App #725003), as well as with funding from the Fraternal Order of Eagles.

Featured News & Stories

Professional headshot of a smiling man wearing round glasses, a navy suit, white shirt, and patterned blue tie, posed against a softly blurred office background.
Research News

Dean Wang Receives Council on Genomic and Precision Medicine Medal of Honor

Dean Wang is the 2026 winner of the Council on Genomic and Precision Medicine Medal of Honor.
Colleen McLaughlin
Department News

Welcoming Colleen McLaughlin, assistant professor, to CDB

The Department of Cell & Developmental Biology (CDB) welcomes Colleen McLaughlin, PhD, as an assistant professor. McLaughlin joins a growing cohort of faculty located in NCRC and is also a member of the Michigan Neuroscience Institute (MNI).
Group of men smiling in a field
News Release

How have diagnostic and treatment decisions for prostate cancer changed in recent years?

An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis by University of Michigan Rogel Cancer Center researchers, indicates a shift toward surveillance in response to concerns of overdiagnosis and overtreatment that have hindered screening in the recent past.
Entrance to Adult Emergency Services with an ambulance parked out front.
Philanthropy News

Small comforts make a world of difference

Thanks to donor support, upgrades like warm blankets, comfortable seating, and snacks are now available in Adult Emergency Services at Michigan Medicine.
Headshot of Dr. Maria Castro
Department News

U.S.-Israel Binational Science Foundation grant for pediatric brain tumor research awarded to co-principal investigators Castro and Friedman-Morbinski

University of Michigan researcher Maria G. Castro and Tel Aviv University researcher Dinorah Friedmann-Morvinski have received a U.S.-Israel Binational Science Foundation grant to study ways to improve CAR T-cell therapy for aggressive pediatric brain tumors. The team will investigate whether combining CAR T cells with treatments that modify the tumor microenvironment can overcome immune suppression and improve outcomes in preclinical models of diffuse hemispheric glioma.
Research image of rat blood vessels before and after norrin treatment
Health Lab

Treatment with norrin helped maintain healthy blood vessels, preserved vision in diabetic rats

Study reveals norrin treatment prevents vision loss from diabetic retinopathy in early and late stages, paving the way for new therapies.